Peripheral Arterial Disease of the Legs (cont.)
White C (2007). Intermittent claudication. New England Journal of Medicine, 356(12): 1241–1250.
Cassar K (2011). Peripheral arterial disease, search date May 2010. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
Hirsch AT, et al. (2006). ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation, 113(11): e463–e654.
Other Works Consulted
Creager MA, et al. (2008). Atherosclerotic peripheral vascular disease symposium II: Executive summary. Circulation, 118(25): 2811–2825.
Creager MA, Libby P (2012). Peripheral arterial diseases. In RO Bonow et al., eds., Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 9th ed., vol. 2, pp. 1338–1358. Philadelphia: Saunders Elsevier.
Fowkes F, Leng GC (2008). Bypass surgery for chronic lower limb ischaemia. Cochrane Database of Systematic Reviews (2).
Hirsch J, et al. (2008). Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 133(6): 71S–109S.
National Heart, Lung, and Blood Institute (2006). Your Guide to Lowering Your Blood Pressure With DASH (NIH Publication No. 06-4082). Available online: http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf.
Norgren L, et al. (2007). Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular Surgery, 33 (Suppl 1): S1–S70.
Olin JW, et al. (2010). ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance measures for adults with peripheral artery disease. Journal of the American College of Cardiology, 56(25): 2147–2181.
Rooke TW, et al. (2011). 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 58(19): 2020–2045.
Smith SC, et al. (2011). AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation, 124(22): 2458–2473.
U.S. Preventive Services Task Force (2005). Screening for peripheral arterial disease. Available online: http://www.uspreventiveservicestaskforce.org/uspstf/uspspard.htm.
U.S. Preventive Services Task Force (2009). Aspirin for the Prevention of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf09/aspirincvd/aspcvdrs.htm.
Wennberg PW, Rooke TW (2011). Diagnosis and management of diseases of the peripheral arteries and veins. In V Fuster et al., eds., Hurst's The Heart, 13th ed., vol. 2, pp. 2331–2346. New York: McGraw-Hill.
eMedicineHealth Medical Reference from Healthwise
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.